Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Anthony Fauci says Omicron-specific COVID-19 vaccine may be prudent but not needed, as clinical trials announced

A COVID-19 vaccine specifically targeting the Omicron variant would be "prudent", even if it ultimately may not be needed, the top US infectious disease official says, as Pfizer announces trials for such a vaccine.

ABC News

Pfizer begins trials of 'tweaked' Covid jab amid fears of waning protection against Omircron

"Emerging data indicate vaccine-induced protection against infection and mild to moderate disease wanes more rapidly than was observed with prior strains"

Irish Mirror

Pfizer and BioNTech launch clinical trial for Omicron-specific vaccine

Pfizer Inc and BioNTech have announced the start a clinical trial to test a new version of their vaccine specifically designed to target the Omicron variant of Covid-19 Omicron variant.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer, BioNTech begin study of omicron-specific COVID vaccine

Pfizer Inc. said it is starting a study of a COVID-19 vaccine that targets the omicron variant, exploring its use in previously vaccinated younger and middle-aged adults as well as those who haven’t received another coronavirus shot.

Tribune News Service

Pfizer, BioNTech Launch Omicron-Targeted COVID-19 Vaccine Trial

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have

Benzinga

Pfizer and BioNTech Launch Trial of Omicron-Targeted COVID Vaccine

Pfizer Inc and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen. The companies plan to test the immune…

Asharq Al-Awsat

The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Pfizer opens study of COVID shots updated to match omicron

Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant

The Independent UK

Pfizer begins clinical trial for Omicron-specific COVID vaccine

Omicron's rise has forced vaccine makers to reassess the effectiveness of their vaccines.

Axios

Pfizer launches Omicron vaccine trial; UK reports highest daily deaths since February – as it happened

Company hopes vaccine will be ready for approval by March; UK reports 439 deaths and more than nearly 95,000 cases

The Guardian - UK

Check Out What Whales Are Doing With PFE

Someone with a lot of money to spend has taken a bearish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows

A third booster dose of a COVID-19 vaccine from either AstraZeneca Plc (NASDAQ: AZN), Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ:

Benzinga

How mRNA and DNA vaccines could soon treat cancers, HIV, autoimmune disorders and genetic diseases

The two most successful coronavirus vaccines developed in the U.S. – the Pfizer and Moderna vaccines – are both mRNA vaccines. The idea of using genetic material to produce an immune response has opened up a world of research and potential medical uses far out of reach of traditional vaccines.…

The Conversation

18-30 trials could help release more Covid vaccines for Africa

Young Londoners are being asked to take part in research that could reduce side-effects from Covid boosters and enable more vaccines to be given to poorer nations.

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

Asharq Al-Awsat

US Provides 1.8 Million Additional Doses of Pfizer COVID Vaccine to Egypt

The US Embassy in Cairo revealed that a new delivery of 1.8 million doses of Pfizer’s coronavirus vaccine arrived in Egypt on Saturday. The vaccines delivery came as part of the US Government’s global efforts to fight the pandemic and were transferred to the Ministry of Health and Population, a…

Bangkok Post

Govt rolls out fourth Covid shot in 10 provinces

The government is ramping up the rollout of fourth Covid-19 shots to residents in tourism-dependent regions as the nation gears up for border reopening next month.

The Guardian - UK

Testing for fully vaccinated travellers to UK to be scrapped; new vaccine pass rules in France – as it happened

UK transport secretary says testing rules for travellers into country will change from 4am on 11 February; new France rules come into force

Wales Online

Pfizer boss backs yearly jabs to fight pandemic

Chief executive says flu-style programme is 'ideal' and signals specialised Omicron vaccine will soon be ready

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Japan and Poland log record cases; Germany seven-day rate at new high – as it happened

Concerns about new Omicron offshoot in England; France to bring in strict restrictions for unvaccinated people

The Times of India

Booster shots are instrumental in fighting Omicron, CDC data show

Booster shots of the Pfizer-BioNTech and Moderna vaccines are not just preventing infections with the contagious omicron variant — they are also keeping infected Americans from ending up in the hospital, according to data published Friday by the Centers for Disease Control and Prevention.

The Independent UK

Booster shots most effective defence against Omicron variant, CDC studies say

Pfizer and Moderna booster shots reduce risk of serious illness or death by as much as 90 per cent, CDC says

Axios

CDC: Pfizer and Moderna boosters overwhelmingly prevent Omicron hospitalizations

The boosters were especially effective in preventing death among Americans over 50.

The Conversation

Australia approves two new medicines in the fight against COVID. How can you get them and are they effective against Omicron?

On Thursday, health minister Greg Hunt announced Australia’s drug regulator had provisionally approved two new medicines for the treatment of COVID.

The Japan News/Yomiuri

Children aged 5-11 OK'd to be vaccinated in Japan

The Health, Labor and Welfare Ministry on Friday gave fast-track approval to the inoculation of children aged 5 to 11 with a coronavirus vaccine from U.S. pharmaceutical firm Pfizer Inc.

Bangkok Post

Pfizer jabs for 5-11s to arrive next week

The next batch of 3 million doses of Pfizer Covid-19 vaccine will arrive in the kingdom on Jan 26 to inoculate children aged five to 11 years, Public Health Minister Anutin Charnvirakul said on Thursday.

1 … 68 69 70 71

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

2,552 stories

International Monetary Fund

World Health Organization

Centers for Disease Control and Prevention

314 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.